A Post-Acute Ocular Tolerability Comparison of Topical Reproxalap 0.25% and Lifitegrast 5% in Patients with Dry Eye Disease

PURPOSE: To assess the subjective eye drop experience of patients with dry eye disease (DED) over approximately 1 hour after a single dose of two formulations of reproxalap versus lifitegrast. METHODS: Two formulations of topical ocular reproxalap 0.25% were evaluated versus lifitegrast ophthalmic s...

Descripción completa

Detalles Bibliográficos
Autores principales: McMullin, David, Clark, David, Cavanagh, Bill, Karpecki, Paul, Brady, Todd C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473572/
https://www.ncbi.nlm.nih.gov/pubmed/34588761
http://dx.doi.org/10.2147/OPTH.S327691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473572/
https://www.ncbi.nlm.nih.gov/pubmed/34588761
http://dx.doi.org/10.2147/OPTH.S327691

Ejemplares similares